Skip to main content

BIOQUAL, Inc.

corporate_fare Company Profile

BIOQUAL, Inc.

BIOQ·OTC·Life Sciences·CIK 0000719711

BIOQUAL, Inc. provides pre-clinical research services, both in-vivo (using living organisms) and in-vitro (using non-living components), to commercial and government clients within the United States. The company offers contract research services focusing on various infectious diseases, including AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, and flavivirus infections such as Zika and dengue, as well as cancer. BIOQUAL also develops and utilizes small and large animal models for research. Its service offerings extend to cell-based assays, immunoassay, toxicology and cytotoxicity testing, and viral load testing. The company also provides tailored assay development services, Biocontainment facilities, imaging services, and animal model development. Furthermore, BIOQUAL offers IND-enabling services, which include toxicology studies, pharmacokinetic profiling, GLP (Good Laboratory Practice) services, and regulatory documentation services. BIOQUAL, Inc. was incorporated in 1981 and operates from Rockville, Maryland.

BIOQUAL, Inc. (OTC:BIOQ) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for BIOQ at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-22, rated 7/10.

Recent high-impact activity:

  • BIOQUAL FY2026 Revenue Drops 18%, Net Loss Widens to $4.2M

Short Interest & Short Volume

On November 20, 2026, 100.0% of BIOQ volume reported to FINRA trade-reporting facilities was marked short.

Daily short volume (FINRA facilities)100.0% of 471 shares on November 20, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$30
52-week range · as of 2026-09-22 $30 – $108.5
Market cap
$26.82M
Volume
471 (0.7× avg)
3-mo avg 707.1
Live data · 2026-11-22 12:42 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BIOQ - Latest Insights

BIOQ
Sep 22, 2026, 2:21 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $33.00
Real-time Price: $30.00 info
Change: -$3.00 (-9%) info
Market Cap: $26.815M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets